ViAqua Therapeutics

ViAqua is developing the first orally administered health management for aquaculture to improve resistance to viral diseases and to prevent viral epidemics.
Now Funding

Founded September 2014
Stage Technology development
Investor The Trendlines Group
CEO Shai Ufaz, PhD

Trendlines’ directors: Nitza Kardish, Steve Rhodes